Tech Company Financing Transactions
CurifyLabs Funding Round
CurifyLabs, operating out of Helsinki, scored $7.5 million in funding from Springvest and Business Finland.
Transaction Overview
Company Name
Announced On
5/27/2025
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Springvest (Lead Investor) (Aki Soudunsaari)
Proceeds Purpose
The funding will be used to scale CurifyLabs' operations and secure high-volume customers in the market.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Salmisaarenaukio 1
Helsinki, 00180
Finland
Helsinki, 00180
Finland
Phone
Website
Email Address
Overview
By modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, quality-controlled production of personalized medicine, customized to provide safe and effective treatment for all patients. Technology developed together with innovative pharmacists on major European markets including Switzerland, Germany and the Netherlands.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlotta Topelius
Chief Financial Officer
Esa-Pekka Romppanen
Chief Operating Officer
Pasi Heiskanen
Chief Technical Officer
Aslak Siimes
Chief Technical Officer
Niklas Topelius
VP - Bus. Development
Sandra Schuele
VP - Engineering
Pontus Lindgren
VP - Regulatory Affairs
Farnaz Shokraneh
VP - Sales
Charles DeAngelis
Browse more venture capital transactions:
Prev: 5/27/2025: SCI Semiconductor venture capital transaction
Next: 5/27/2025: Cerebro Capital venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs